Published in Appl Microbiol on December 01, 1973
Ethylenimine-inactivated rabies vaccine of tissue culture origin. J Clin Microbiol (1976) 0.88
Polyoma transformation of hamster cell clones--an investigation of genetic factors affecting cell competence. Virology (1962) 24.93
Application of agar-gel diffusion analysis to a study of the antigenic structure of inactivated vaccines prepared from the virus of foot-and-mouth disease. J Immunol (1959) 1.53
Factors affecting the production of foot-and-mouth disease virus in deep suspension cultures of BHK21 clone 13 cells. J Hyg (Lond) (1967) 1.22
Improvements in the design of laboratory apparatus for the suspended culture of tissue cells. Lab Pract (1966) 0.97
[Antirabies vaccines from tissue culture obtained with the Pasteur strain. Results of vaccination]. Ann Inst Pasteur (Paris) (1972) 0.90
An inactivated baby hamster kidney cell rabies vaccine for use in dogs and cattle. Res Vet Sci (1971) 0.89
IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol (1996) 5.38
Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. J Virol (2001) 4.98
The ribonucleic acids of the infective and interfering components of vesicular stomatitis virus. J Gen Virol (1967) 2.57
The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science (1994) 2.53
Regulation of the immune response. I. Suppression of delayed-type hypersensitivity by T cells from mice expressing humoral immunity. Eur J Immunol (1976) 2.36
Is the acetylcholine receptor a rabies virus receptor? Science (1982) 2.30
Specificity and development of cytotoxic thymus-derived lymphocytes in lymphocytic choriomeningitis. J Immunol (1974) 2.23
IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide. J Immunol (1999) 2.05
A case for cytokines as effector molecules in the resolution of virus infection. Immunol Today (1993) 2.02
Infective virus substructure from vesicular stomatitis virus. J Virol (1967) 1.89
Oxaliplatin-induced damage of cellular DNA. Mol Pharmacol (2000) 1.73
Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2. J Immunol (1990) 1.67
CD40 ligand has potent antiviral activity. Nat Med (1995) 1.64
Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection. J Exp Med (1990) 1.56
Immunodeficient mice recover from infection with vaccinia virus expressing interferon-gamma. Eur J Immunol (1990) 1.52
Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo. J Virol (1996) 1.52
Sequence- and region-specificity of oxaliplatin adducts in naked and cellular DNA. Mol Pharmacol (1998) 1.50
The growth and persistence of foot-and-mouth disease virus in the bovine mammary gland. J Hyg (Lond) (1971) 1.41
Efficacy of DNA and fowlpox virus priming/boosting vaccines for simian/human immunodeficiency virus. J Virol (2004) 1.39
Discrimination of suppressor T cells of humoral and cell-mediated immunity by anti-Ly and anti-Ia sera. Cell Immunol (1977) 1.33
Lysis of herpesvirus-infected cells by immune spleen cells. Infect Immun (1975) 1.32
Contaminant lead in blood-collection tubes for trace-element studies. Clin Chem (1992) 1.27
Factors affecting the production of foot-and-mouth disease virus in deep suspension cultures of BHK21 clone 13 cells. J Hyg (Lond) (1967) 1.22
Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo. Proc Natl Acad Sci U S A (1991) 1.22
Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent. J Exp Med (1984) 1.20
Immunobiology of infection with recombinant vaccinia virus encoding murine IL-2. Mechanisms of rapid viral clearance in immunocompetent mice. J Immunol (1991) 1.16
Infertility in mice induced by a recombinant ectromelia virus expressing mouse zona pellucida glycoprotein 3. Biol Reprod (1998) 1.12
Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus. J Virol (1994) 1.12
DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors. Immunol Cell Biol (1997) 1.11
Analysis of the inhibition of tumour metastasis by sulphated polysaccharides. Int J Cancer (1987) 1.11
Rhabdoviridae. Report of the Rhabdovirus Study Group, International Committee on Taxonomy of Viruses. Intervirology (1979) 1.07
Efficacy of rabies vaccine prepared from virus grown in duck embryo. Lancet (1970) 1.05
Cytokines and murine autoimmune encephalomyelitis: inhibition or enhancement of disease with antibodies to select cytokines, or by delivery of exogenous cytokines using a recombinant vaccinia virus system. Scand J Immunol (1995) 1.03
Differential expression of a novel gene, WDNM1, in nonmetastatic rat mammary adenocarcinoma cells. Cancer Res (1988) 1.03
Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity. Immunol Rev (1999) 1.02
Enhanced cellular immunity in macaques following a novel peptide immunotherapy. J Virol (2005) 1.02
Nitric oxide production is increased during murine vaccinia virus infection, but may not be essential for virus clearance. Virology (1996) 1.01
Bacteriuria in a population-based cohort of women. J Infect Dis (1978) 1.00
Regulation of the immune response. II. Repressor T cells in cyclophosphamide-induced tolerant mice. Eur J Immunol (1977) 1.00
Recombinant viruses as vaccines and immunological tools. Curr Opin Immunol (1997) 1.00
The vaccination of man and other animals against rabies. Postgrad Med J (1973) 0.99
A study of the interference phenomenon in vesicular stomatitis virus replication. Arch Gesamte Virusforsch (1969) 0.98
Some functional and morphological alterations occurring during and after the adaptation of BHK 21 clone 13 cells to suspension culture. Exp Cell Res (1966) 0.98
Viral subunits for rabies vaccination. Nature (1969) 0.98
Interference as a measure of cross-relationships in the vesicular stomatitis group of rhabdo viruses. J Gen Virol (1973) 0.97
A new isolate of Lagos bat virus from the Republic of South Africa. Trans R Soc Trop Med Hyg (1982) 0.94
Genotypic analysis of cutaneous T-cell lymphomas. J Invest Dermatol (1987) 0.94
In vivo interference in vesicular stomatitis virus infection. Infect Immun (1977) 0.93
Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIV CD8(+) cytotoxic T-cell epitopes. J Virol (1999) 0.92
IFN-gamma, TNF, and IL-6 production by vaccinia virus immune spleen cells. An in vitro study. J Immunol (1994) 0.90
An interfering component of rabies virus which contains RNA. J Gen Virol (1974) 0.90
A recombinant vaccinia virus encoding the interferon-inducible T-cell alpha chemoattractant is attenuated in vivo. Scand J Immunol (2004) 0.90
Genotypic analysis of large cell lymphomas which express the Ki-1 antigen. Histopathology (1987) 0.90
A requirement for helper T cells in the induction of delayed-type hypersensitivity. J Immunol (1983) 0.90
Transcriptional and posttranscriptional activation of urokinase plasminogen activator gene expression in metastatic tumor cells. Cancer Res (1992) 0.90
An inactivated baby hamster kidney cell rabies vaccine for use in dogs and cattle. Res Vet Sci (1971) 0.89
T-cell mediated immunity towards antigen(s) on isologous erythrocytes. Nature (1977) 0.88
The effects of succimer on the absorption of lead in adults determined by using the stable isotope 204Pb. Environ Res (1994) 0.88
A recombinant vaccinia virus encoding inducible nitric oxide synthase is attenuated in vivo. J Virol (1996) 0.88
Oral-contraceptive use and bacteriuria in a community-based study. N Engl J Med (1978) 0.88
Growth of the IB-RS-2 pig kidney cell line in suspension culture and its susceptibility to foot-and-mouth disease virus. Appl Microbiol (1971) 0.87
Lectin-binding characteristics of related high- and low-metastatic rat mammary adenocarcinoma cell lines. Invasion Metastasis (1987) 0.86
IFN-gamma regulates murine interferon-inducible T cell alpha chemokine (I-TAC) expression in dendritic cell lines and during experimental autoimmune encephalomyelitis (EAE). Scand J Immunol (2002) 0.86
Cytokines in innate and adaptive immunity. Rev Immunogenet (2000) 0.86
Isolation of gene associated with high metastatic potential in rat mammary adenocarcinomas. J Natl Cancer Inst (1990) 0.85
The in vitro induction of T cells which mediate delayed-type hypersensitivity toward horse red blood cells. Cell Immunol (1979) 0.85
Involvement of plasminogen activator production with tumor metastasis in a rat model. Cancer Res (1984) 0.85
Stimulation by heterotypic antigens of foot-and-mouth disease virus antibodies in vaccinated cattle. Res Vet Sci (1982) 0.84
Serological and immunological relations between the 146S and 12S particles of foot-and-mouth disease virus. J Gen Virol (1980) 0.84
Enhancement of mucosal IgA responses by interleukins 5 and 6 encoded in recombinant vaccine vectors. Reprod Fertil Dev (1994) 0.84
The use of cell fusion to analyse factors involved in tumour cell metastasis. Int J Cancer (1983) 0.83
A 6-thioguanine-resistant variant of the 13762 cell line which is no longer tumorigenic or metastatic. Int J Cancer (1982) 0.83
Surface properties of cells involved in antibody-dependent cytotoxicity. Cell Immunol (1976) 0.83
Proposal for a uniform nomenclature for defective interfering viruses of vesicular stomatitis virus. J Virol (1980) 0.82
Sporobolomyces: a possible cause of extrinsic allergic alveolitis. J Allergy Clin Immunol (1983) 0.82
Recombinant vaccine vector-induced protection of athymic, nude mice from influenza A virus infection. Analysis of protective mechanisms. Scand J Immunol (1992) 0.82
Interfering component of vesicular stomatitis virus. Nature (1966) 0.82
Spontaneous capillary tube migration of metastatic rat mammary adenocarcinoma cells. Invasion Metastasis (1984) 0.82
DNA immunization. Immunol Cell Biol (1997) 0.82
Effect of an iron-chelating agent on lymphocyte proliferation. Aust J Exp Biol Med Sci (1984) 0.81
The role for host-immune factors in the in vivo antiviral effects of tumour necrosis factor. Cytokine (1995) 0.81
Hemostatic studies in patients with infective endocarditis: a report on nine consecutive cases with evidence of coagulopathy. Heart Vessels (1991) 0.81
A blastogenic test for foot-and-mouth disease. J Hyg (Lond) (1979) 0.81
Practical value of genotypic analysis for diagnosing lymphoproliferative disorders. J Clin Pathol (1987) 0.81
Rejection of allogeneic tumor cells growing in mouse cerebrospinal fluid. Functional analysis of the inflammatory process. J Neuroimmunol (1981) 0.80
Induction of HIV-1-specific T-helper responses and type 1 cytokine secretion following therapeutic vaccination of macaques with a recombinant fowlpoxvirus co-expressing interferon-gamma. J Med Primatol (2000) 0.80
A recombinant avipoxvirus HIV-1 vaccine expressing interferon-gamma is safe and immunogenic in macaques. Vaccine (2000) 0.79
Loss of antiviral cytotoxic T-lymphocyte activity during high-level antigen stimulation. Viral Immunol (1998) 0.79
Rapid identification of swine vesicular disease virus in vesicular epithelium using the fluorescent antibody technique. Res Vet Sci (1973) 0.79
Immunology cross-reactivity between spinal cord protein and myelin basic protein. Int Arch Allergy Appl Immunol (1982) 0.79
Neurotensin receptor-mediated inhibition of pancreatic cancer cell growth by the neurotensin antagonist SR 48692. Anticancer Res (1999) 0.78
Enhanced plasminogen activator production by highly metastatic variant cell lines of a rat mammary adenocarcinoma. Invasion Metastasis (1986) 0.78
Induction of AT-specific DNA-interstrand crosslinks by bizelesin in genomic and simian virus 40 DNA. Biochim Biophys Acta (1999) 0.78
Vaccinia-interleukin 2 recombinant virus or exogenous interleukin 2 does not alter the magnitude or immune response gene defects of the cytotoxic T-cell response to vaccinia virus in vivo. Scand J Immunol (1989) 0.78
The antiviral activity of tumour necrosis factor on herpes simplex virus type 1: role for a butylated hydroxyanisole sensitive factor. Arch Virol (1995) 0.77
Polymorphic electrophile response elements in the mouse glutathione S-transferase GSTa1 gene that confer increased induction. Cancer Lett (2001) 0.77
Studies on rat mammary adenocarcinomas: a model for metastasis. Cancer Metastasis Rev (1985) 0.77
The enhancement of human tumor necrosis factor-alpha antiviral activity in vivo by monoclonal and specific polyclonal antibodies. Lymphokine Cytokine Res (1993) 0.77